Y-mAbs Therapeutics, Inc.·4

Dec 13, 4:11 PM ET

Lisby Steen 4

4 · Y-mAbs Therapeutics, Inc. · Filed Dec 13, 2018

Insider Transaction Report

Form 4
Period: 2018-12-11
Lisby Steen
Sr VP & CMO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2018-12-11+20,00020,000 total
    Exercise: $21.97Exp: 2028-12-11Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The stock option shall vest and become exercisable as to 25% of the shares subject to the option on December 11, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

Documents

1 file
  • 4
    a4.xmlPrimary

    4